Granulocyte-macrophage colony-stimulating factor given as an adjuvant to persons not responding to hepatitis B vaccine

被引:15
作者
Carlsson, T
Struve, J
机构
[1] Danderyd Hospital,Dept. of Infectious Diseases, Karolinska Institute
关键词
D O I
10.1007/BF02113594
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
引用
收藏
页码:129 / 129
页数:1
相关论文
共 5 条
[1]  
JONES T, 1994, EUR J CLIN MICROB S2, V13, P47
[2]   RANDOMIZED PLACEBO-CONTROLLED TRIAL OF RECOMBINANT INTERLEUKIN-2 IN CHRONIC UREMIC PATIENTS WHO ARE NONRESPONDERS TO HEPATITIS-B VACCINE [J].
JUNGERS, P ;
DEVILLIER, P ;
SALOMON, H ;
CERISIER, JE ;
COUROUCE, A .
LANCET, 1994, 344 (8926) :856-857
[3]  
MEUER SC, 1989, LANCET, V1, P15
[4]   SEROCONVERSION AFTER ADDITIONAL VACCINE DOSES TO NONRESPONDERS TO 3 DOSES OF INTRADERMALLY OR INTRAMUSCULARLY ADMINISTERED RECOMBINANT HEPATITIS-B VACCINE [J].
STRUVE, J ;
ARONSSON, B ;
FRENNING, B ;
FORSGREN, M ;
WEILAND, O .
SCANDINAVIAN JOURNAL OF INFECTIOUS DISEASES, 1994, 26 (04) :468-470
[5]  
Taglietti M, 1995, ADV EXP MED BIOL, V378, P565